Process to prepare pioglitazone via several novel intermediates

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

07465801

ABSTRACT:
A novel process for preparing thiazolidinediones, preferably Pioglitazone, as described. Also described are novel intermediates involved in its synthesis and process for their preparation and use in medicine.

REFERENCES:
patent: 0 008 203 (1980-02-01), None
patent: 0 193 256 (1986-09-01), None
patent: 0 257 781 (1988-03-01), None
patent: WO 93/22445 (1993-11-01), None
patent: WO 02/088120 (2002-11-01), None
Sohda T. et al; “Studies on antidiabetic agents, synthesis and hypoglycemic activity of 5-A4-(pyridylalkoxy)benzylU-2,4-thiazolidinediones”; Arzneimittel Forschung, Drug Research, Editio Cantor. Aulendorf, DE, vol. 40, No. 1; Jan. 1990; pp. 37-42, XP002188063; ISSN: 0004-4172.
Momose Y. et al; “Studies on antidiabetic agents. X. 1) synthesis and biological activities of pioglitazone and related compounds”; Chemical and Pharmaceutical Bulletin, Pharmaceutical Society of Japan, Tokyo, JP; vol. 39, No. 6, Jun. 1, 1990; pp. 1440-1445, XP002042765.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Process to prepare pioglitazone via several novel intermediates does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process to prepare pioglitazone via several novel intermediates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process to prepare pioglitazone via several novel intermediates will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4038304

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.